HomeSYRS • OTCMKTS
add
Syros Pharmaceuticals Inc
Previous close
$0.00020
Day range
$0.00020 - $0.0030
Year range
$0.00010 - $0.10
Market cap
4.02K USD
Avg Volume
33.76K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.66M | — |
Net income | -6.40M | — |
Net profit margin | — | — |
Earnings per share | -0.16 | 88.15% |
EBITDA | -25.86M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 58.28M | — |
Total assets | 85.00M | — |
Total liabilities | 96.12M | — |
Total equity | -11.12M | — |
Shares outstanding | 26.83M | — |
Price to book | -0.00 | — |
Return on assets | -68.28% | — |
Return on capital | -126.59% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.40M | — |
Cash from operations | -20.69M | — |
Cash from investing | 0.00 | — |
Cash from financing | 0.00 | — |
Net change in cash | -20.69M | — |
Free cash flow | -11.00M | — |
About
Founded
2011
Website
Employees
68
